Single Dose of Psilocybin Linked to Lasting Improvements in Well-Being, Study Finds

Researchers are continuing to explore how psilocybin, the active compound found in “magic mushrooms,” affects the brain not just in the moment, but over time. In a small, early study published in Nature Communications, scientists looked at whether a single high dose could lead to lasting changes in brain structure, function and overall well-being.

The study included 28 healthy adults who had never used psychedelics before. Participants received either a high dose of psilocybin (25 mg) or a very low dose (1 mg, used as a placebo), and investigators followed them from one hour after dosing up to one month later using brain scans and psychological assessments.

The results showed that those who received the higher dose experienced meaningful improvements in how they felt and thought one month later. Participants reported greater overall well-being, increased psychological insight and improved cognitive flexibility, which refers to the ability to adapt thinking, shift perspectives and respond to new situations. These types of changes are often associated with better mental health and resilience, suggesting that psilocybin may influence not just mood but also how people process their thoughts and experiences.

“Psychedelic means ‘psyche-revealing,’ or making the psyche visible,” said senior investigator Robin Carhart-Harris, Ph.D., the Ralph Metzner Distinguished Professor of Neurology at UC San Francisco. “Our data show that such experiences of psychological insight relate to an entropic quality of brain activity and how both are involved in causing subsequent improvements in mental health. It suggests that the trip — and its correlates in the brain — is a key component of how psychedelic therapy works.”

Brain imaging provided additional clues about what might be happening beneath the surface. The team observed subtle structural changes in areas of the brain involved in decision-making and emotional regulation, particularly in pathways connected to the prefrontal cortex. They also found that the brain’s communication patterns appeared to become less rigid or “modular,” meaning different regions may have been interacting more freely.

Interestingly, the degree of this change was linked to improvements in well-being, echoing patterns seen in other mental health research. In the hours immediately after taking psilocybin, participants also showed increased “signal complexity” in brain activity — essentially a more dynamic pattern of brain signaling — which predicted better emotional outcomes one month later. A sense of psychological insight the following day appeared to play a role in connecting these early brain changes to longer-term benefits.

“Psilocybin seems to loosen up stereotyped patterns of brain activity and give people the ability to revise entrenched patterns of thought,” explained senior investigator Taylor Lyons, Ph.D., a research associate at Imperial College London. “The fact that these changes track with insight and improved well‑being is especially exciting.”

At the same time, the study found that most long-term functional brain changes were limited, suggesting that the benefits may come less from permanent rewiring and more from how the brain processes the experience itself. It’s also important to note that participants who received the very low dose did not show these effects, highlighting the importance of dosage.

While these findings are promising, this research is still in its early stages. The study was small, included only healthy individuals and looked at the effects of just one dose. Still, the results add to growing interest in how psychedelic therapies might one day support mental health by enhancing insight, flexibility and emotional well-being.

“We already knew psilocybin could be helpful for treating mental illness,” said Carhart-Harris. “But now we have a much better understanding of how.”